{"id":"sparc1104-modified-dose-regimen-ii","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is unknown, but it is believed to work through a specific molecular target. Further research is needed to fully understand its effects on the body.","oneSentence":"SPARC1104 is a modified dose regimen of an undisclosed drug, but it is likely a small molecule targeting a specific molecular pathway.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:35:41.856Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Undisclosed indication"}]},"trialDetails":[{"nctId":"NCT01797185","phase":"PHASE3","title":"Safety Study of SPARC1104","status":"COMPLETED","sponsor":"Sun Pharma Advanced Research Company Limited","startDate":"2013-04-09","conditions":"Spasticity","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SPARC1104 modified dose regimen II","genericName":"SPARC1104 modified dose regimen II","companyName":"Sun Pharma Advanced Research Company Limited","companyId":"sun-pharma-advanced-research-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SPARC1104 is a modified dose regimen of an undisclosed drug, but it is likely a small molecule targeting a specific molecular pathway. Used for Undisclosed indication.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}